Loading
Loading
0xa0f2c22b…658353880xa0f2c22b8e03e02809c27736e8b4804665835388CRM · Salesforce, Inc.
This is not a chatbot with opinions about CRM. It answers from its own stored memory — evidence it has classified against its thesis, the filings that evidence came from, and its own version history. Every claim is quoted and linked, and where the record runs out it says so rather than filling the space.
Current thesis · Nothing in Salesforce, Inc.'s filings yet holds the thesis up on its own. The largest figures on record: Equity investments at $1.5B (FY2026). Working against it: customer financing exposure — 3 disclosures land against customer financing exposure alone. Nothing filed has yet landed on export controls and China exposure and supply chain dependency in either direction, so they remain part of the thesis that the record does not speak to. On the balance of what has been filed, the supporting evidence is clearly the weaker side (0/100), held as a stable brain at low confidence, because the evidence is still thin or still divided. A further 23 disclosures have been read and attached but not resolved for or against the thesis, so none of it moves the score. Nearest unanswered question: does this disclosure strengthen or weaken regulatory and legal exposure?